Could a tiny device free people with type 1 diabetes from daily shots?
Disease control
Ongoing
This early-stage trial tests a small device placed under the skin that contains insulin-producing cells. The goal is to see if it is safe and tolerable for people with type 1 diabetes who already receive standard islet transplants. Only 10 participants are enrolled, and the main …
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC